These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19287466)

  • 21. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.
    Riemersma SA; Jordanova ES; Schop RF; Philippo K; Looijenga LH; Schuuring E; Kluin PM
    Blood; 2000 Nov; 96(10):3569-77. PubMed ID: 11071656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary central nervous system diffuse large B cell lymphoma: a clinicopathologic and molecular study].
    Ma ZP; Ainiwaer B; Liu ZY; Shi XL; Cui WL; Zhang W; Li XX
    Zhonghua Bing Li Xue Za Zhi; 2016 Nov; 45(11):762-768. PubMed ID: 27821230
    [No Abstract]   [Full Text] [Related]  

  • 23. Aberrant ERG expression associates with downregulation of miR-4638-5p and selected genomic alterations in a subset of diffuse large B-cell lymphoma.
    Zhang S; Wang L; Cheng L
    Mol Carcinog; 2019 Oct; 58(10):1846-1854. PubMed ID: 31237044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas.
    Aggarwal N; Swerdlow SH; Kelly LM; Ogilvie JB; Nikiforova MN; Sathanoori M; Nikiforov YE
    Mod Pathol; 2012 Sep; 25(9):1203-11. PubMed ID: 22575864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H; Ludwig N; Fehlmann T; Menegatti J; Gröger L; Anastasiadou E; Trivedi P; Keller A; Meese E; Grässer FA
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system.
    Baraniskin A; Kuhnhenn J; Schlegel U; Chan A; Deckert M; Gold R; Maghnouj A; Zöllner H; Reinacher-Schick A; Schmiegel W; Hahn SA; Schroers R
    Blood; 2011 Mar; 117(11):3140-6. PubMed ID: 21200023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study.
    Marchesi F; Regazzo G; Palombi F; Terrenato I; Sacconi A; Spagnuolo M; Donzelli S; Marino M; Ercolani C; Di Benedetto A; Blandino G; Ciliberto G; Mengarelli A; Rizzo MG
    J Exp Clin Cancer Res; 2018 May; 37(1):95. PubMed ID: 29716630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of simian virus 40 in diffuse large B-cell lymphomas in Tunisia correlates with germinal center B-cell immunophenotype, t(14;18) translocation, and P53 accumulation.
    Amara K; Trimeche M; Ziadi S; Laatiri A; Mestiri S; Sriha B; Mokni M; Korbi S
    Mod Pathol; 2008 Mar; 21(3):282-96. PubMed ID: 18165800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS and non-AIDS diffuse large B-cell lymphomas express different antigen profiles.
    Madan R; Gormley R; Dulau A; Xu D; Walsh D; Ramesh KH; Cannizaro L; Tamas EF; Kumar P; Sparano J; LeValley A; Xue X; Bhattacharyya PK; Ioachim HL; Ratech H
    Mod Pathol; 2006 Mar; 19(3):438-46. PubMed ID: 16444194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of microRNA-223 and its clinicopathologic correlation in diffuse large B-cell lymphoma].
    Yao XX; Wang JF; Wang YH; Gao N
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):366-70. PubMed ID: 22932402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffuse large B-cell lymphoma involving the central nervous system.
    Gualco G; Weiss LM; Barber GN; Bacchi CE
    Int J Surg Pathol; 2011 Feb; 19(1):44-50. PubMed ID: 21087986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas.
    Bhagavathi S; Sharathkumar A; Hunter S; Sung L; Kanhere R; Venturina MD; Wilson JD
    Clin Neuropathol; 2008; 27(1):13-20. PubMed ID: 18257470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary testicular diffuse large B-cell lymphoma shows an activated B-cell-like phenotype.
    Li D; Xie P; Mi C
    Pathol Res Pract; 2010 Sep; 206(9):611-5. PubMed ID: 20627604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targetable genetic features of primary testicular and primary central nervous system lymphomas.
    Chapuy B; Roemer MG; Stewart C; Tan Y; Abo RP; Zhang L; Dunford AJ; Meredith DM; Thorner AR; Jordanova ES; Liu G; Feuerhake F; Ducar MD; Illerhaus G; Gusenleitner D; Linden EA; Sun HH; Homer H; Aono M; Pinkus GS; Ligon AH; Ligon KL; Ferry JA; Freeman GJ; van Hummelen P; Golub TR; Getz G; Rodig SJ; de Jong D; Monti S; Shipp MA
    Blood; 2016 Feb; 127(7):869-81. PubMed ID: 26702065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.
    Garcia-Reyero J; Martinez Magunacelaya N; Gonzalez Pereña A; Marcos Gonzalez S; Teran-Villagra N; Azueta A; Batlle A; Gonzalez de Villambrosia S; Revert Arce J; Montes-Moreno S
    Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):e68-e71. PubMed ID: 29629945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity and complexes of mTOR in diffuse large B-cell lymphomas--a tissue microarray study.
    Sebestyén A; Sticz TB; Márk A; Hajdu M; Timár B; Nemes K; Nagy N; Váradi Z; Kopper L
    Mod Pathol; 2012 Dec; 25(12):1623-8. PubMed ID: 22899290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening and identification of differentially expressed microRNAs in diffuse large B-cell lymphoma based on microRNA microarray.
    Gao HX; Li SJ; Wang MB; Yan SF; Cui WL; Ma ZP; Xue J; Sang W; Zhang W; Li XX
    Oncol Lett; 2021 Nov; 22(5):753. PubMed ID: 34539857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of ataxia-telangiectasia mutated protein expression in diffuse large B-cell lymphomas of primary central nervous system and non-central nervous system origin.
    Kim SH; Cheong JW; Park KH; Kim TS; Yang WI
    Arch Pathol Lab Med; 2007 Mar; 131(3):457-67. PubMed ID: 17516749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.
    Landsburg DJ; Petrich AM; Abramson JS; Sohani AR; Press O; Cassaday R; Chavez JC; Song K; Zelenetz AD; Gandhi M; Shah N; Fenske TS; Jaso J; Medeiros LJ; Yang DT; Nabhan C
    Cancer; 2016 Feb; 122(4):559-64. PubMed ID: 26565895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderly.
    Andrade TA; Evangelista AF; Campos AH; Poles WA; Borges NM; Camillo CM; Soares FA; Vassallo J; Paes RP; Zerbini MC; Scapulatempo C; Alves AC; Young KH; Colleoni GW
    Oncotarget; 2014 Dec; 5(23):11813-26. PubMed ID: 25544772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.